Home » Topics » Regulatory » EMA

EMA
RSS

EMEA recommends withdrawal of benfluorex from the market in E.U.

Dec. 28, 2009

Bayer Schering withdraws European MAA for Recothrom (thrombin alfa)

Dec. 16, 2009

GSK withdraws centralized MAA for Zunrisa in postoperative nausea and vomiting

Oct. 16, 2009

CHMP issues positive opinion for Baxter's Celvapan H1N1 pandemic influenza vaccine

Oct. 6, 2009

E.C. approves Novartis' Focetria vaccine for use in the H1N1 influenza pandemic

Oct. 1, 2009

EMEA withdraws marketing authorization for Posaconazole SP

Aug. 7, 2009

GlaxoSmithKline withdraws MAA for Bosatria

Aug. 3, 2009

European CHMP recommends marketing authorization for Tigenix's ChondroCelect

July 2, 2009

CHMP adopts positive opinion for Otsuka's Samsca in hyponatremia

June 12, 2009

CHMP recommends granting of marketing authorization for Orphan Europe's Vedrop

June 11, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...